NCT03695731

Brief Summary

Influence of diabetic neuropathy on cold induced brown adipose tissue in type 1 diabetic patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 4, 2018

Completed
11 days until next milestone

Study Start

First participant enrolled

October 15, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 15, 2019

Completed
Last Updated

May 9, 2019

Status Verified

May 1, 2019

Enrollment Period

1 year

First QC Date

September 26, 2018

Last Update Submit

May 7, 2019

Conditions

Keywords

diabetesbrown adipose tissueenergy expenditureglycemic controlneuropathy18F-FDG PET-RMI

Outcome Measures

Primary Outcomes (1)

  • brown adipose tissue activation

    PET- MRI measurement (SUVR)

    120 minutes after cold exposure

Secondary Outcomes (1)

  • Energy expenditure

    before and 120 minutes after cold exposure

Study Arms (2)

Patients without Neuropathy

EXPERIMENTAL

activation of cold induced brown adipose tissue

Procedure: cold induced activation of brown adipose tissue

Patients with Neuropathy

EXPERIMENTAL

activation of cold induced brown adipose tissue

Procedure: cold induced activation of brown adipose tissue

Interventions

cold exposure wearing a cold life jacket

Patients with NeuropathyPatients without Neuropathy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 1 diabetes
  • Patients who can understand the issue of this study and who are able to decide for themselves whether or not to participate in the study.
  • Adult patient (\>18 years old)
  • Informed Consent form signed
  • Group A: absence of neuropathy
  • Group B: significant neuropathy

You may not qualify if:

  • Treatment with beta-blockers
  • Alcohol consumption(\> 50 gr/week)
  • Allergy to 18F-FDG
  • Participation in another clinical study (4 weeks prior to entry) that may influence the activity of brown adipose tissue
  • Pregnancy
  • Exposure to ionizing radiation greater than or equal to 5 mSv during the year preceding the PET-RMI planned in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geneva University Hospital

Geneva, 1205, Switzerland

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Giacomo Gastaldi, Dr.

    University Hospital, Geneva

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Giacomo Gastaldi, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 26, 2018

First Posted

October 4, 2018

Study Start

October 15, 2018

Primary Completion

October 15, 2019

Study Completion

October 15, 2019

Last Updated

May 9, 2019

Record last verified: 2019-05

Locations